NCT06261567View on ClinicalTrials.gov

A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health Service

CompletedOBSERVATIONAL

Enrollment

415

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

August 20, 2024

Study Completion Date

August 20, 2024

Conditions

Asthma

Interventions

DRUG

Biologic treatment

Patients receiving treatment with any biologic treatment for severe asthma which is approved within the UK NHS. These include omalizumab, mepolizumab, reslizumab, benralizumab and/or dupilumab

Trial Locations (4)

Unknown

Research Site, Birmingham

Research Site, London

Research Site, Manchester

Research Site, Southampton